首页> Cancer> Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma.

Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma.

导出原文传递

翻译打印收藏纠错

第一作者： Nicolas,Leupin

第一单位： Argenx, Zwijnaarde, Belgium.

作者： Nicolas,Leupin ^[1] ; Pier Luigi,Zinzani ^[2] ; Franck,Morschhauser ^[3] ; Stéphane,Dalle ^[4] ; Marie,Maerevoet ^[5] ; Jean-Marie,Michot ^[6] ; Vincent,Ribrag ^[6] ; Fritz,Offner ^[7] ; Marie,Beylot-Barry ^[8] ; Hélène,Moins-Teisserenc ^[9] ; Karen,Zwaenepoel ^[10] ; Koen,de Winne ^[10] ; Maxime,Battistella ^[9] ; Anna,Hultberg ^[1] ; Domenica,Gandini ^[1] ; Mahan,Moshir ^[1] ; Julie,Jacobs ^[1] ; Tim,Delahaye ^[1] ; Aitzaz,Khan ^[1] ; Piotr,Zabrocki ^[1] ; Karen,Silence ^[1] ; Luc,van Rompaey ^[1] ; Christophe,Borg ^[11] ; Giovanna,Motta ^[12] ; Federica,Melle ^[12] ; Angelica,Calleri ^[12] ; Patrick,Pauwels ^[10] ; Hans,de Haard ^[1] ; Stefano,Pileri ^[12] ; Martine,Bagot ^[13]

作者单位： Argenx, Zwijnaarde, Belgium. ^[1] IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.;Istituto di Ematologia "Seràgnoli," Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università degli Studi, Bologna, Italy. ^[2] Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Université de Lille, CHU Lille, EA 7365, Lille, France. ^[3] Department of Dermatology, Centre Hospitalier Lyon Sud, Pierre Bénite, France. ^[4] Service Hématologie, Institut Jules Bordet, Brussels, Belgium. ^[5] Gustave Roussy, Villejuif, France. ^[6] University Hospital Gent, Gent, Belgium. ^[7] Inserm U1053, Department of Dermatology, Centre Hospitalier, Bordeaux, France. ^[8] Hôpital Saint Louis, Université de Paris, INSERM U1160, Paris, France. ^[9] Department of Pathology, University Hospital Antwerp, Edegem, Belgium. ^[10] Inserm U645, Centre Hospitalier Universitaire de Besançon, Besançon, France. ^[11] Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy. ^[12] Inserm U976, Hôpital Saint Louis, Université de Paris, Paris, France. ^[13]

关键词 CD70 clinical trial cusatuzumab cutaneous T-cell lymphoma (CTCL)translational

医学主题词抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);人类(Humans);淋巴瘤, T细胞, 皮肤(Lymphoma, T-Cell, Cutaneous);肿瘤复发, 局部(Neoplasm Recurrence, Local);皮肤肿瘤(Skin Neoplasms);治疗结果(Treatment Outcome)

DOI 10.1002/cncr.34005

PMID 34726773

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交